Marc André

7.1k citations

121 papers · 1.7k indexed · h-index 19

Impact in

Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in ⓘ

Pathology and Forensic Medicine 81
- Lymphoma Diagnosis and Treatment 81
Genetics 31
- Chronic Lymphocytic Leukemia Research 28

Co-authors: André Bosly (8 shared papers)Augustin Ferrant (5 shared papers)Pauline Brice (18 shared papers)Gregor Verhoef (4 shared papers)Regina Kunzmann (2 shared papers)Pierre W. Wijermans (2 shared papers)Michael Lübbert (2 shared papers)Christophe Ravoet (2 shared papers)
Journals: Blood (34 papers)Journal of Clinical Oncology (14 papers)Hematological Oncology (11 papers)British Journal of Haematology (4 papers)Haematologica (4 papers)
Partner nations: Belgium France United States

In The Last Decade

Marc André

110 papers receiving 1.7k citations

Peers

Countries citing papers authored by Marc André

Since Specialization

Citations

This map shows the geographic impact of Marc André's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc André with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc André more than expected).

Fields of papers citing papers by Marc André

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc André. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc André. The network helps show where Marc André may publish in the future.

Co-authors

The 25 scholars most cited alongside Marc André, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc André Line = papers co-authored together Marc André links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2'-deoxycytidine British Journal of Haematology ·Michael Lübbert, Pierre W. Wijermans, Regina Kunzmann, Gregor Verhoef, André Bosly, Christophe Ravoet, Marc André, Augustin Ferrant	2001	175
2	Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology ·Hervé Tilly, Umberto Vitolo, Jan Walewski, María Gomes da Silva, Ofer Shpilberg, Marc André, Michael Pfreundschuh, M. Dreyling	2012	122
3	Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin’s disease: analysis of 280 patients from the French registry Bone Marrow Transplantation ·Pauline Brice, Réda Bouabdallah, Philippe Moreau, Marine Diviné, Marc André, Malek Aoudjane, J Fleury, Bruno Anglaret, André Baruchel, Luc Sensebé, P Colombat, (unknown)	1997	112
4	Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients Blood ·Marc André	2003	110
5	Risk-Adapted Salvage Treatment With Single or Tandem Autologous Stem-Cell Transplantation for First Relapse/Refractory Hodgkin's Lymphoma: Results of the Prospective Multicenter H96 Trial by the GELA/SFGM Study Group Journal of Clinical Oncology ·Franck Morschhauser, Pauline Brice, Christophe Fermé, Marine Diviné, Gilles Salles, Réda Bouabdallah, Catherine Sebban, Laurent Voillat, Olivier Casasnovas, Aspasia Stamatoullas, Krimo Bouabdallah, Marc André, Jean-Philippe Jaı̈s, Dominique Cazals‐Hatem, Christian Gisselbrecht	2008	90
6	ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial Annals of Oncology ·Nicolas Mounier, Pauline Brice, Serge Bologna, Josette Brière, Isabelle Gaillard, Marian Heczko, Jean Gabarre, Olivier Casasnovas, J. Jaubert, Philippe Colin, Alain Delmer, A. Devidas, Emmanuel Bachy, Emmanuelle Nicolas‐Virelizier, A. Aoudjhane, Catherine Humbrecht, Marc André, Patrice Carde	2014	66
7	FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study Blood ·Olivier Casasnovas, Loïc Ysebaert, Catherine Thiéblemont, Emmanuel Bachy, Patrick Feugier, Alain Delmer, Sabine Tricot, Jean Gabarre, Marc André, Christophe Fruchart, Nicolas Mounier, Richard Delarue, Michel Meignan, Alina Berriolo-Riedinger, Stéphane Bardet, J Emile, Jean-Philippe Jaı̈s, Corinne Haïoun, Hervé Tilly, F. Morschhauser	2017	62
8	Quantitative and qualitative analysis of metabolic response at interim positron emission tomography scan combined with International Prognostic Index is highly predictive of outcome in diffuse large B-cell lymphoma Leukemia & lymphoma ·Nathalie Nols, Nicolas Mounier, Salima Bouazza, Renaud Lhommel, S Costantini, Thierry Vander Borght, Marie‐Christiane Vekemans, Anne Sonet, André Bosly, Lucienne Michaux, Marc André, Éric Van Den Neste	2013	59
9	Feasibility of tandem autologous stem-cell transplantation (ASCT) in induction failure or very unfavorable (UF) relapse from Hodgkin's disease (HD) Annals of Oncology ·Pauline Brice, Marine Diviné, D. Simon, Bertrand Coiffier, V. Leblond, M. Simon, L. Voilat, A. Devidas, Franck Morschhauser, Pierre‐Simon Rohrlich, Marc André, Éric Lepage, Christophe Fermé	1999	57
10	Adjunctive Salvage Therapy with Inhaled Aminoglycosides for Patients with Persistent Smear-Positive Pulmonary Tuberculosis Clinical Infectious Diseases ·Leonard Sacks, Stella Pendle, Dragana Orlovic, Marc André, Mirjana Popara, George A. Moore, L. Thonell, Selwyn J. Hurwitz	2001	47
11	A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma Haematologica ·Éric Van Den Neste, Marc André, Thomas Gastinne, Aspasia Stamatoullas, Corinne Haïoun, Amine Belhabri, Oumédaly Reman, Olivier Casasnovas, Hervé Ghesquières, Gregor Verhoef, Marie-José Claessen, Hélène A. Poirel, Marie‐Christine Copin, Romain Dubois, Peter Vandenberghe, Ioanna-Andrea Stoian, Anne‐Ségolène Cottereau, Sarah Bailly, Laurent Knoops, Franck Morschhauser	2018	42
12	Retrograde Acucise® Endopyelotomy: Long-Term Results Journal of Endourology ·É. Lechevallier, C. Eghazarian, Jean-Claude Ortega, Marc André, Ève Gelsi, Christian Coulange	1999	35
13	Classical Hodgkin's lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant Haematologica ·Eric Van Den Neste, Olivier Casasnovas, Marc André, Mohamed Touati, Delphine Sénécal, Véronique Edeline, Aspasia Stamatoullas, Luc Mathieu Fornecker, Bénédicte Deau, T. Gastinne, Oumédaly Reman, Isabelle Gaillard, Cécile Borel, Pauline Brice, Christophe Fermé	2013	35
14	Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma Leukemia ·Eric Van Den Neste, I Louviaux, Jl. Michaux, André Delannoy, Lucienne Michaux, Anne Sonet, André Bosly, Chantal Doyen, Philippe Mineur, Marc André, Nicole Straetmans, E Coche, Christian Venet, Thierry Duprez, Augustin Ferrant	2000	35
15	Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma. Journal of Clinical Oncology ·Jessica Conti, Nancy Kemeny, Karen Seiter, Erdem Göker, Tong Wei, Marc André, K Ragusa, J.R. Bertino	1994	35
16	A quantitative study of peripheral blood stem cell contamination in diffuse large‐cell non‐Hodgkin's lymphoma: one‐half of patients significantly mobilize malignant cells British Journal of Haematology ·Caroline Jacquy, Anne Soree, Frédéric Lambert, André Bosly, Augustin Ferrant, Marc André, Jasmine Parma, Alain Kentos, Philippe Martiat	2000	30
17	Interim Analysis of the Randomized Eortc/Lysa/Fil Intergroup H10 Trial On Early PET-Scan Driven Treatment Adaptation in Stage I/II Hodgkin Lymphoma Blood ·Marc André, Oumédaly Reman, Massimo Federico, T. Girinski, Pauline Brice, Ercole Brusamolino, Christophe Fermé, Richard vander Maazen, Monica Bellei, Catherine Sebban, Franck Morschhauser, Elly Lugtenburg, A. Stamatoulas, Catherine Fortpied, Michel Meignan, Annibale Versari, Martin Hutchings, John Raemaekers	2012	28
18	Tubulocystic renal cell carcinoma: a new radiological entity European Radiology ·F. Cornélis, O. Hélénon, Jean-Michel Corréas, L. Lemaître, Marc André, Jean‐Yves Meuwly, Christian Sengel, Lorenzo E. Derchi, M. Yacoub, Virginie Verkarre, N. Grenier	2015	22
19	Cytogenetic responses in high‐risk myelodysplastic syndrome following low‐dose treatment with the DNA methylation inhibitor 5‐aza‐2′‐deoxycytidine British Journal of Haematology ·Michael Lübbert, Pierre W. Wijermans, Regina Kunzmann, Gregor Verhoef, André Bosly, Christophe Ravoet, Marc André, Augustin Ferrant	2001	22
20	The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA Blood Advances ·Lieselot Buedts, Iwona Włodarska, Julio Finalet-Ferreiro, Olivier Gheysens, Luc Dehaspe, Thomas Tousseyn, Luc‐Matthieu Fornecker, Julien Lazarovici, Olivier Casasnovas, Anne‐Claire Gac, Christophe Bonnet, Kamal Bouabdallah, Christiane Copie‐Bergman, Bettina Fabiani, Daan Dierickx, Lukas Marcelis, Joris Vermeesch, Marc André, Peter Vandenberghe	2021	18

About Marc André

Marc André is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Neurology, having authored 121 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (81 papers), Chronic Lymphocytic Leukemia Research (28 papers), Lung Cancer Treatments and Mutations (23 papers), CAR-T cell therapy research (21 papers), CNS Lymphoma Diagnosis and Treatment (17 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Viral-associated cancers and disorders (10 papers) and Cancer Genomics and Diagnostics (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Genetics (329 citations), Oncology (731 citations), Neurology (394 citations) and Hematology (253 citations). Marc André has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include André Bosly, Augustin Ferrant, Pauline Brice, Gregor Verhoef, Regina Kunzmann, Pierre W. Wijermans, Michael Lübbert, Christophe Ravoet, Olivier Casasnovas and Marine Diviné. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, British Journal of Haematology and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact